Search results
- Basel, 16 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a human papillomavirus (HPV) self-sampling solution in countries accepting the CE mark. This new solution enables a patient to privately collect her sample for HPV screening while at a healthcare facility, following instructions provided by a healthcare worker.
Jun 16, 2022 · Roche’s self-sampling solution helps reduce these barriers by offering women an alternative to more invasive clinician collection procedures, while also providing accurate and reliable results enabling clinicians to make patient care decisions.
People also ask
Does Roche have a self-testing kit for papillomavirus (HPV)?
What is Roche's HPV self sampling solution?
How does Roche's self sampling solution help prevent cervical cancer?
Does 2 Roche offer a Cobas HPV test for cervical cancer?
May 14, 2024 · Roche’s human papillomavirus (HPV) self-collection solution will improve access to testing by providing women the option to privately collect their own sample.
May 15, 2024 · Roche's innovative human papillomavirus self-collection solution offers a breakthrough in cervical cancer screening, providing accessible and reliable testing to combat underscreening rates and increase early detection.
May 15, 2024 · BERLIN, May 15 (Reuters) - Swiss drugmaker Roche (ROG.S) on Wednesday said the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-testing kit. Screening...
Jun 16, 2022 · Roche’s HPV self sampling solution expands access to HPV screening options by enabling patients to privately collect their sample while at a healthcare facility.
- F. Hoffmann-La Roche Ltd
May 15, 2024 · Roche announced the FDA approval of its human papillomavirus (HPV) self-collection solution, one of the first available in the United States. Screening for HPV can help identify women who are at risk of developing cervical cancer so that the disease can be found and treated early before cervical cancer has a chance to develop.
May 15, 2024 · Roche announced that the FDA has approved its human papillomavirus(HPV) self-collection solution, one of the first of its kind approved in the United States. According to the company, the new tool allows individuals to collect their own samples in a healthcare setting for HPV testing, supporting early detection and prevention of cervical cancer.
